NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
Top Cited Papers
- 1 August 2005
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 366 (9486) , 649-659
- https://doi.org/10.1016/s0140-6736(05)67137-1
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based studyCancer Letters, 2005
- Investigation of genetic polymorphisms and smoking in a bladder cancer case–control study in ArgentinaCancer Letters, 2004
- Polymorphisms in DNA repair and metabolic genes in bladder cancerCarcinogenesis: Integrative Cancer Research, 2003
- POLYMORPHISMS OF N-ACETYLTRANSFERASE 2, GLUTATHIONE S-TRANSFERASE MU AND THETA GENES AS RISK FACTORS OF BLADDER CANCER IN RELATION TO ASTHMA AND TUBERCULOSISJournal of Urology, 2000
- Glutathione S–Transferase Null Genotypes in Transitional Cell Bladder CancerEuropean Urology, 2000
- Genetic metabolic polymorphisms and the risk of cancer: a review of the literatureBiomarkers, 1996
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part ICritical Reviews in Biochemistry and Molecular Biology, 1995
- Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogensEuropean Journal Of Cancer, 1993
- Confidence Interval Estimation of InteractionEpidemiology, 1992
- Some Statistical Methods for Combining Experimental ResultsInternational Journal of Technology Assessment in Health Care, 1990